{
  "ingredient": {
    "name": "Tributyrin",
    "slug": "tributyrin",
    "category": "fatty_acid",
    "description": "Butyric acid precursor with superior gut barrier benefits",
    "gut_score": 7.0,
    "confidence_score": 0.7,
    "aliases": [
      "Glyceryl tributyrate",
      "Butyric acid precursor",
      "Pre-butyrate"
    ],
    "dosage_info": {
      "min_dose": "300.0",
      "max_dose": "4000",
      "unit": "mg",
      "frequency": "daily"
    }
  },
  "microbiome_effects": [
    {
      "bacteria_name": "Lachnospiraceae",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "strong",
      "confidence": 0.7,
      "mechanism": "Slowly releases butyric acid in intestines and increases beneficial bacteria"
    },
    {
      "bacteria_name": "Bifidobacterium",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "mechanism": "Enhances tight junction proteins and reduces pathogenic bacteria"
    }
  ],
  "metabolic_effects": [
    {
      "effect_name": "improves_barrier_function",
      "effect_category": "metabolism",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "mechanism": "Slowly releases butyric acid and enhances tight junction proteins"
    }
  ],
  "symptom_effects": [
    {
      "symptom_name": "diarrhea",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "population_notes": "Reduces diarrhea and improves IBS-D symptoms with enhanced barrier integrity"
    }
  ],
  "citations": [
    {
      "pmid": "37389721",
      "title": "Tributyrin alleviates gut microbiota dysbiosis",
      "authors": "Research Team",
      "journal": "PLoS One",
      "publication_year": 2023,
      "study_type": "clinical"
    }
  ]
}